Drug Approval | October 20, 2021
FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Second interchangeable biosimilar product approved by agency
Second interchangeable biosimilar product approved by agency
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
The Amplitude Solution gives laboratories the ability to scale Covid-19 PCR testing and process up to 8,000 samples a day
The survey revealed that improving customer experience (CX) and operational efficiencies are top priorities, which healthcare organizations aim to attain by deploying digital health solutions
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
It has planned an investment of over Rs 80 crore in the next five years
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
The drug is being developed at lab scale for the first-line of treatment of Covid-19
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
Subscribe To Our Newsletter & Stay Updated
